Differentiation syndrome in patients with acute promyelocytic leukemia

A 48‐year‐old male diagnosed with acute promyelocytic leukemia (APL) started on all‐trans‐retinoic acid and arsenic trioxide, developed typical symptoms of differentiation syndrome, and improved dramatically on steroids. Hence, any APL patient started on chemotherapy, needs to be monitored closely f...

Descripción completa

Detalles Bibliográficos
Autores principales: Elamin, Nusiba H., Rashid, Farah, Afana, Muhammad S., Cherif, Honar, Yassin, Mohamed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Images
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880381/
https://www.ncbi.nlm.nih.gov/pubmed/36721680
http://dx.doi.org/10.1002/ccr3.6697
_version_ 1784878897096032256
author Elamin, Nusiba H.
Rashid, Farah
Afana, Muhammad S.
Cherif, Honar
Yassin, Mohamed A.
author_facet Elamin, Nusiba H.
Rashid, Farah
Afana, Muhammad S.
Cherif, Honar
Yassin, Mohamed A.
author_sort Elamin, Nusiba H.
collection PubMed
description A 48‐year‐old male diagnosed with acute promyelocytic leukemia (APL) started on all‐trans‐retinoic acid and arsenic trioxide, developed typical symptoms of differentiation syndrome, and improved dramatically on steroids. Hence, any APL patient started on chemotherapy, needs to be monitored closely for developing differentiation syndrome and to start steroid upon suspicion.
format Online
Article
Text
id pubmed-9880381
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-98803812023-01-30 Differentiation syndrome in patients with acute promyelocytic leukemia Elamin, Nusiba H. Rashid, Farah Afana, Muhammad S. Cherif, Honar Yassin, Mohamed A. Clin Case Rep Case Images A 48‐year‐old male diagnosed with acute promyelocytic leukemia (APL) started on all‐trans‐retinoic acid and arsenic trioxide, developed typical symptoms of differentiation syndrome, and improved dramatically on steroids. Hence, any APL patient started on chemotherapy, needs to be monitored closely for developing differentiation syndrome and to start steroid upon suspicion. John Wiley and Sons Inc. 2023-01-26 /pmc/articles/PMC9880381/ /pubmed/36721680 http://dx.doi.org/10.1002/ccr3.6697 Text en © 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Images
Elamin, Nusiba H.
Rashid, Farah
Afana, Muhammad S.
Cherif, Honar
Yassin, Mohamed A.
Differentiation syndrome in patients with acute promyelocytic leukemia
title Differentiation syndrome in patients with acute promyelocytic leukemia
title_full Differentiation syndrome in patients with acute promyelocytic leukemia
title_fullStr Differentiation syndrome in patients with acute promyelocytic leukemia
title_full_unstemmed Differentiation syndrome in patients with acute promyelocytic leukemia
title_short Differentiation syndrome in patients with acute promyelocytic leukemia
title_sort differentiation syndrome in patients with acute promyelocytic leukemia
topic Case Images
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880381/
https://www.ncbi.nlm.nih.gov/pubmed/36721680
http://dx.doi.org/10.1002/ccr3.6697
work_keys_str_mv AT elaminnusibah differentiationsyndromeinpatientswithacutepromyelocyticleukemia
AT rashidfarah differentiationsyndromeinpatientswithacutepromyelocyticleukemia
AT afanamuhammads differentiationsyndromeinpatientswithacutepromyelocyticleukemia
AT cherifhonar differentiationsyndromeinpatientswithacutepromyelocyticleukemia
AT yassinmohameda differentiationsyndromeinpatientswithacutepromyelocyticleukemia

Ejemplares similares